M&A Deal Summary

AmeriPath Acquires Specialty Laboratories

On January 31, 2006, AmeriPath acquired healthcare services company Specialty Laboratories

Acquisition Highlights
  • This is AmeriPath’s 2nd transaction in the Healthcare Services sector.
  • This is AmeriPath’s 2nd transaction in the United States.
  • This is AmeriPath’s 1st transaction in California.

M&A Deal Summary

Date 2006-01-31
Target Specialty Laboratories
Sector Healthcare Services
Buyer(s) AmeriPath
Deal Type Merger

Target

Specialty Laboratories

Valencia, California, United States
Specialty Laboratories supports local pathology and community-based medicine by partnering with pathologists and hospitals to improve patient care and reduce episodes-of-care costs. Specialty offers hospitals an extensive menu of highly advanced clinical tests used by physicians to diagnose, monitor and treat disease and a single-source solution for esoteric testing needs.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

AmeriPath

Orlando, Florida, United States

Category Company
Sector Healthcare Services
DESCRIPTION

AmeriPath, Inc. is a leading national provider of anatomic pathology, dermatopathology and molecular diagnostic services to physicians, hospitals, clinical laboratories and surgery centers across the U.S.


DEAL STATS #
Overall 2 of 2
Sector: Healthcare Services M&A 2 of 2
Type: Merger M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2006 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2000-11-09 Inform DX

Nashville, Tennessee, United States

InformDX is an anatomic pathology and diagnostic information provider, with eleven labs in major markets. InformDX invests capital and management resources in the field to create locally dominant providers in markets with proven growth potential.

Buy -